Garrelts J C
Via Christi-St. Francis, Wichita, KS 67214, USA.
Pharm Pract Manag Q. 1996 Jul;16(2):36-40.
Pharmacoeconomic information is rapidly becoming an accepted format for evaluating and comparing various treatment options. Such information may either supplement or replace standard methods for evaluating new drugs for possible inclusion on the formulary. It is important to recognize the pitfalls that may accompany different methods of collecting and evaluating pharmacoeconomic studies. Such information is important because drug use and outcomes in a real-world setting may differ substantially from those within the confines of a clinical trial setting.
药物经济学信息正迅速成为评估和比较各种治疗方案的一种可接受的形式。此类信息可能补充或取代评估新药是否可能被列入药品目录的标准方法。认识到不同的收集和评估药物经济学研究方法可能存在的缺陷很重要。此类信息之所以重要，是因为在现实环境中的药物使用和结果可能与临床试验环境中的情况有很大不同。
